Patient #4 HER2+ re-post: Prior to enrolling in the trial, the patient had 18 identifiable tumor spots in the brain.

At approximately two months following the start of weekly 700 mg doses of leronlimab, only three lesions were identifiable, as detected by MRI.

https://investorshangout.com/post/view?id=6753101
____
For me, that is still one of the most stunning testimonies ...